Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa (Virtual)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-25
SponsorUniversity of California, San Francisco

About this trial

The goal of this clinical trial is to evaluate whether a narrative medicine (NM) curriculum can enhance self-expression, reflection, and resilience in adolescents and young adults with anorexia nervosa.

The main questions it aims to answer are:

* Does participation in an NM curriculum improve self-expression and reflection in individuals with anorexia nervosa? * Does engaging in creative writing and group discussion promote resilience and emotional processing in this population?

Participants will be 16-25 years old, medically stable for outpatient eating disorder therapy, and actively engaged in treatment. Those with active suicidal ideation, recent non-suicidal self-injury, or a co-occurring personality disorder will not be eligible.

Participants will:

* Attend six weekly workshops focused on themes such as self-definition, kindness, resilience, and possibility * Engage in close reading of visual or written texts * Complete creative writing exercises in response to prompts * Participate in group discussions and sharing

An optional capstone reading event will provide a supportive space for participants to share their work with peers, loved ones, and providers, fostering connection and community.

This study aims to explore the role of narrative medicine in eating disorder treatment and assess its potential benefits for psychological well-being and self-expression.

Eligibility criteria

Qualifiers

16-25 years old

have a DSM-5 diagnosis of AN (confirmed by the UCSF Eating Disorders Program clinical team),

currently engaged in outpatient eating disorder treatment, ensuring medical stability and capacity for a group-based intervention

English fluency to engage in reflective writing and discussions

Disqualifiers

Currently medically unstable or require inpatient hospitalization

History of psychosis, schizophrenia spectrum disorder, bipolar disorder, or personality disorder

Severe neurocognitive impairment that would prevent engagement with the intervention

Active suicidal ideation or non-suicidal self-injury within the past two months

Trial design

Treatments tested in this trial

  • Narrative Medicine (NM) Workshop Series

Treatment groups

10 Participants
are divided into 1 treatment group